{"PixelsPerMicron": 1.5384615948919735, "FirstGroup": "Introduction", "FirstViewport": {"Zoom": 9.49869494554826, "Pan": [0.674933608170274, 0.8066237510950417]}, "Images": [{"Name": "i0", "Description": "Ovarian Cancer with Annotation - LSP15343", "Path": "https://s3.amazonaws.com/www.cycif.org/gray-stic-1", "Width": 43262, "Height": 27936, "MaxLevel": 6}], "Header": "This sample was taken from a BRCA1 mutant patient (female, age 71 years) who underwent a risk reduction surgery to remove the ovaries and fallopian tubes (bilateral salpingo-oophorectomy; BSO). The patient had a history of bilateral breast cancer, twice previously.\n\nUpon surgery, the patient was diagnosed with Stage 1C High-Grade Serous Ovarian Carcinoma (HGSOC). A 6 mm tumor was found in her right fallopian tube, along with pre-cancerous lesions, including p53 signatures, serous tubal intraepithelial lesions (STIL), and serous tubal intraepithelial carcinoma (STIC). The tumor was found only in fallopian tube. Therefore, there was no involvement in the ovary.    \n\n--\n\n# Metadata about this sample  \n\n### Diagnosis  \n**Age at diagnosis:**  71  \n**Primary diagnosis:**  HGSOC  \n**Surgery type:** bilateral salpingo-oophorectomy (BSO)  \n**Stage at diagnosis:** IC  \n**Fallopian involvement:**  Yes; Right FT (STIC, 6 mm HGSOC)  \n**Ovarian involvement:** No  \n**Genetic features:** BRCA1-mutant  \n**Molecular features:** p53- mutant  \n**Metastatic sites:** None  \n\n### Demographics  \n**Species:** Human  \n**Sex:** Female  \n**Race:** White  \n**Ethnicity:** Non-hispanic or latino  \n**Age at Surgery:** 71 years  \n**Vital status at last follow-up:** Alive. Started Anastrozole and Olaparib in 2021 and 2022, respectively -present.  \n**Age at last follow-up:** 73 \n\n### Clinical history\n**Cancer history:** Yes - two prior grade 3 breast cancers  \n**Prior therapeutic agents:** Chemotherapy  \n**Surgical history:** Bilateral mastectomy  \n\n### Therapy\n**Treatment type:** Post-surgical chemotherapy  \n**Therapeutic agents:** Carboplatin and Taxol (Chemotherapeutic agents), Anastrozole and Olaparib. \n\n### Imaging  \n**Imaging Assay Type:** t-CyCIF  \n**Fixative Type:** FFPE  \n**Microscope:** RareCyte CyteFinder 46  \n**Objective:** 20x /0.75 NA  \n**Binned:** Yes  \n\n### Attribution  \n**Please cite this Minerva Story as:**  \nKader, Tanjina, Lin, Jia-Ren and Coy, Shannon. Ovarian Cancer with Annotation - LSP15343. Harvard Dataverse. V1, 2023, [DOI](DOI).  \n\n### Sample Identifiers  \n|ID Type |\tID |\n|--|--|\n|**LSP Slide ID:**  |\tLSP15343 |\n| **UPenn ID:**  | Case ID RD-23-005 |  \n\n--", "Rotation": 0, "Layout": {"Grid": [["i0"]]}, "Stories": [{"Name": "", "Description": "", "Waypoints": []}], "Channels": [{"Rendered": false, "Name": "DNA", "Path": "DNA-0_4__DNA"}, {"Rendered": false, "Name": "CD103", "Path": "CD103-0_20__CD103"}, {"Rendered": false, "Name": "LAG3", "Path": "LAG3_27__LAG3"}, {"Rendered": false, "Name": "PD1", "Path": "PD1_24__PD1"}, {"Rendered": false, "Name": "CD8a", "Path": "CD8a_11__CD8a"}, {"Rendered": false, "Name": "CD103", "Path": "CD103-0_20__CD103"}, {"Rendered": false, "Name": "PanCK", "Path": "PanCK_10__PanCK"}, {"Rendered": false, "Name": "CD11c", "Path": "CD11c_43__CD11c"}, {"Rendered": false, "Name": "DNA", "Path": "DNA-0_4__DNA"}, {"Rendered": false, "Name": "CD163", "Path": "CD163_36__CD163"}, {"Rendered": false, "Name": "p53", "Path": "p53_7__p53"}], "Groups": [{"Name": "TRM in tumor", "Colors": ["ffffff", "2aa52a", "ff00ff", "0000ff"], "Channels": ["DNA", "CD103", "LAG3", "PD1"], "Descriptions": ["Hoechst", "Tissue resident memory T cells", "", ""]}, {"Name": "Immune_Tumor", "Colors": ["ffffff", "ff00ff", "00ffff"], "Channels": ["DNA", "CD8a", "CD103"], "Descriptions": ["Hoechst", "Cytotoxic T cells", "Tissue resident memory T cells"]}, {"Name": "Tumor", "Colors": ["ffffff", "ff8300"], "Channels": ["DNA", "PanCK"], "Descriptions": ["Hoechst", "epithelial marker"]}, {"Name": "STIC", "Colors": ["ffffff", "ff00ff", "ff8300", "00ffff"], "Channels": ["DNA", "CD8a", "PanCK", "CD11c"], "Descriptions": ["Hoechst", "Cytotoxic T cells", "epithelial marker", "Dendritic cells if CD69 and CD163 negative"]}, {"Name": "Other immune cells", "Colors": ["ffffff", "00ffff", "ff00ff"], "Channels": ["DNA", "CD11c", "CD163"], "Descriptions": ["Hoechst", "Dendritic cells if CD69 and CD163 negative", "M2 macrophage"]}, {"Name": "Introduction", "Colors": ["ffffff", "ff0000"], "Channels": ["DNA", "p53"], "Descriptions": ["Hoechst", "HGSOC has a background TP53 mutation"]}], "Masks": []}
